The study also found that women with a history of GLP-1 use had a 30% higher risk of developing gestational diabetes, a ...
The Wegovy pill is expected to hit the market in January, joining injectable GLP-1 drugs that have transformed obesity treatment. One form you swallow, the other you inject. What else is different?
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback